Your browser doesn't support javascript.
loading
Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.
Kaito, Yuta; Sugimoto, Emi; Nakamura, Fumi; Tsukune, Yutaka; Sasaki, Makoto; Yui, Shunsuke; Yamaguchi, Hiroki; Goyama, Susumu; Nannya, Yasuhito; Mitani, Kinuko; Tamura, Hideto; Imai, Yoichi.
Afiliação
  • Kaito Y; Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Tokyo.
  • Sugimoto E; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo.
  • Nakamura F; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi.
  • Tsukune Y; Department of Hematology, Juntendo University School of Medicine, Tokyo.
  • Sasaki M; Department of Hematology, Juntendo University School of Medicine, Tokyo.
  • Yui S; Department of Hematology, Nippon Medical School, Tokyo.
  • Yamaguchi H; Department of Hematology, Nippon Medical School, Tokyo.
  • Goyama S; Division of Molecular Oncology, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo.
  • Nannya Y; Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Tokyo.
  • Mitani K; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi.
  • Tamura H; Division of Diabetes, Endocrinology and Hematology, Department of Internal Medicine, Dokkyo Medical University Saitama Medical Center, Saitama.
  • Imai Y; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi. imaiyo-tky@umin.ac.jp.
Haematologica ; 109(4): 1107-1120, 2024 Apr 01.
Article em En | MEDLINE | ID: mdl-37731380

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteínas de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteínas de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article